Palonosetron has been found to be effective in treating chemotherapy-induced nausea and vomiting, but no other studies that have compared it with the other 5-HT3 RAs are currently available.
Many clinicians have been preparing for USP for a long time and are well on their way to compliance.
If IVIG is commenced within 2 weeks from the onset of Guillain-Barre syndrome it can hasten recovery as much as plasma exchange, study indicates.
This study assesses the preferences of patients with cystic fibrosis for treatments that differ in the mode of administration.
The second half of a 2-part series on the influential women shaping the specialty pharmacy industry.
A controlled substances diversion prevention program (CSDPP) that aligns with the revised ASHP guidelines is critical to ensure patients are protected from occurrences of drug diversion.
This study demonstrated that a linezolid PA program did not appear to be associated with a negative impact on medical outcomes and was associated with lower costs.
Generic atorvastatin led to an increase in generic dispensing rate and a reduction in the cost of treatment for patients requiring cholesterol-lowering treatment. The upcoming introduction of the PCSK9 inhibitor may change this trend.
Help patients choose appropriate medications and direct them to a physician, when necessary
Exploring how health plans and hemophilia treatment centers can better work together to deliver high-quality care and manage costs associated with hemophilia.
Originating from damage within nerve cells themselves, neuropathic pain is often complex, with many treatment challenges.
Clinicians often reserve vigilance with drug-related issues for critically ill patients or older populations, while mistaking the resilience of childhood as a protective barrier.
While not everything on this list is a law, they are all at least best practices and/or tips to most efficiently comply with a law or regulation, and to get your job done.
Pharmacists should familiarize themselves with these therapies to help patients lessen the risk of emergency department visits and hospitalizations.
In 2017, lung cancer is projected to be the second most prevalent type of cancer in the United States, with about 222,500 new cases and is estimated to still be the leading cause of cancer-related death, with 155,870 deaths.
Adherence measurement can help patients achieve better outcomes.
Combining medication history information from multiple sources improves the completeness and accuracy of the medication information.
Pharmacists can motivate patients to stick to their drug regimens to decrease viral load and prevent further transmission.
Clarian Health, an 11-hospital health system, developed and managed a multihospital formulary through focused planning and collaboration.
Whether it be delivery options, remote pharmacy, increasing roles for pharmacists and technicians, or fluctuating patient volume, the impact of COVID-19 can be felt in community pharmacies across the United States.
Morristown Medical Center’s area-based pharmacist program leads to an increase in direct patient contact and opportunities for interventions.
Combining pegilodecakin (AM0010) with nivolumab (Opdivo) or pembrolizumab (Keytruda) induced an overall response rate (ORR) of 41% in patients with advanced non–small cell lung cancer (NSCLC), according to findings from an early phase study presented at the 2018 ASCO Annual meeting.
Some medication combinations are a source of preventable drug-related harm. A multifaceted approach is needed to address this quality-of-care issue.
This study linked e-prescribing records to paid pharmacy claims to identify primary nonadherence rates and factors associated with unfilled prescriptions.